Related Experiment Videos
Therapeutic targets for osteoarthritis
1Stoke Mandeville Hospital, Rheumatology, Aylesbury HP218AL, UK. sally.Edmonds@buckshosp.nhs.uk
Abstract:
Osteoarthritis (OA) is a multi-factorial disease, which, as the population ages, puts an ever increasing burden on health care resources. The treatment of OA, in terms of disease modifying drugs, has lagged well behind that of the inflammatory arthritides, and it may be that research in this area has been misguided. It is unlikely that a single therapy will be effective in what is a very heterogeneous condition. There is evidence that OA should be thought of as a disease of the whole musculoskeletal system, affecting not only cartilage, but also muscle, ligaments, bone and even adipose tissue. In developing novel therapies, greater attention needs to be given to the mechanics of the joint environment. Whilst, as yet, there is no disease modifying therapy available for the treatment of OA, many of the existing, more conservative therapies have been shown to be effective. In particular, the management of obesity is important both for the prevention and progression of the disease. Other interventions, such as exercise therapy and visco-supplementation also have their place. However, patient compliance with these therapies is often less than optimal and looking for ways of improving this may be an area for future research.
Insights
Osteoarthritis (OA) is a complex condition affecting the entire musculoskeletal system. Current treatments focus on conservative management and lifestyle changes, as disease-modifying drugs are still under development.
Area of Science:
- Orthopedics and Rheumatology
- Gerontology
- Biomedical Engineering
Background:
- Osteoarthritis (OA) is a progressive, multifactorial musculoskeletal disease with increasing healthcare costs due to an aging population.
- Disease-modifying treatments for OA have lagged behind inflammatory arthropathies, suggesting current research directions may need re-evaluation.
- OA is increasingly recognized as a systemic condition impacting cartilage, bone, muscle, ligaments, and adipose tissue, necessitating a holistic approach.
Purpose of the Study:
- To review the current understanding of osteoarthritis (OA) as a complex musculoskeletal disease.
- To highlight the limitations in disease-modifying drug development for OA.
- To emphasize the importance of conservative management strategies and future research directions.
Main Methods:
- Literature review of osteoarthritis pathophysiology and treatment modalities.
- Analysis of current therapeutic approaches, including conservative management and emerging therapies.
- Discussion of the challenges in OA treatment and patient compliance.
Main Results:
- OA is a heterogeneous condition affecting the entire musculoskeletal system, not just cartilage.
- Effective conservative therapies include obesity management, exercise, and visco-supplementation.
- No disease-modifying therapy is currently available for OA treatment.
Conclusions:
- Future OA therapies should consider the biomechanics of the joint environment and the systemic nature of the disease.
- Improving patient compliance with existing conservative treatments is crucial.
- Further research is needed to develop effective disease-modifying treatments for osteoarthritis.
Related Concept Videos
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: